Takeda Joins Structural Genomics Consortium - Bio-IT World

abernard102@gmail.com 2012-08-20


“April 6, 2012 | Takeda Pharmaceutical has joined the Structural Genomics Consortium (SGC), a public-private partnership that supports the discovery of new medicines through open access research. SGC is based at the Universities of Toronto, Canada, and Oxford, England and consisting of six pharma companies. Takeda's contribution raises the SGC's funds to $50 million. The SGC's research network helps Takeda promote its drug discovery efforts by accessing new research first hand. The company also can influence the research direction of the SGC network by participating on the SGC Scientific Committee and its Board of Directors. Press release”




08/16/2012, 06:08

From feeds:

Open Access Tracking Project (OATP) » abernard102@gmail.com


oa.medicine oa.biology oa.new oa.comment oa.uk oa.funding oa.japan oa.pharma oa.oxford.u oa.biomedicine oa.canada oa.consortia oa.u.toronto oa.sgc oa.announcements



Date tagged:

08/20/2012, 18:27

Date published:

04/08/2012, 16:11